Click here to view Phynova's corporate presentation (2.1MB)
Power of
Plants
Mankind has for centuries
relied on plants as a valuable source of therapeutic agents to treat disease and maintain good health. Using traditional Chinese medicines (TCM) as a discovery engine and starting point, Phynova develops patent-protected pharmaceuticals, OTC drugs, cosmetic and functional ingredients.
Drug Candidates
Melokinex™ POI
For Post Operative Ileus
Phytobacx™ MRSA
For MRSA and Acne
PYN17 HEPATITIS C
Chronic Hepatitis C
PYN22 Obesity/NAFLD
For Obesity/Non Alcoholic Fatty Liver Disease ('NAFLD')
PYN18 Antivirals
Hepatitis C Virus and Dengue
Consumer Healthcare
THMPs
Multiple indications to be registered under THMP Directive
Relivergen™
Supplement for general liver health
IminoNorm™
Supplement for blood-glucose control
FatigFix™
Supplement for fatigue and troubled sleep
Pipeline
Phynova has identified a number of Drug Candidates in the fields of anti-virals, anti-microbials, gasteroenterology, and anti-inflammatories, as well as developing products for the OTC and Consumer and Personal Healthcare markets.
News
Phynova Promotes Three New Ingredients at VitaFoods 2011
Phynova is pleased to announce their participation at Vitafoods 2011 in Geneva from 10-12 May... More